MMWR Morb Mortal Wkly Rep. 1992 Mar 6;41(9):152-5.
Influenza and its complications remain a major cause of premature death and debilitating illness in the United States, particularly among older persons and those with chronic medical conditions. However, only 30% of persons greater than or equal to 65 years of age responding to the 1989 National Health Interview Survey reported having received influenza vaccine during the previous year (CDC, unpublished data, 1991). In 1988, the Health Care Financing Administration (HCFA) and CDC began a congressionally mandated 4-year demonstration project to evaluate the cost-effectiveness of providing influenza vaccine under Medicare. This report reviews preliminary results of the Medicare Influenza Vaccine Demonstration during 1988-1992.
在美国，流感及其并发症仍然是导致过早死亡和使人衰弱疾病的主要原因，在老年人和患有慢性疾病的人群中尤为如此。然而，在1989年全国健康访谈调查中，年龄大于或等于65岁的受访者中，只有30%报告称上一年接种了流感疫苗（疾病控制与预防中心，未公布数据，1991年）。1988年，医疗保健财务管理局（HCFA）和疾病控制与预防中心启动了一项由国会授权的为期4年的示范项目，以评估医疗保险项下提供流感疫苗的成本效益。本报告回顾了1988 - 1992年医疗保险流感疫苗示范项目的初步结果。
